Submandibular Gland Biopsy for the Diagnosis of Parkinson Disease

ABSTRACTThe clinical diagnosis of Parkinson disease (PD) is incorrect in 30% or more of subjects particularly at the time of symptom onset. Because Lewy-type α-synucleinopathy is present in the submandibular glands of PD patients, we assessed the feasibility of submandibular gland biopsy for diagnos...

Full description

Saved in:
Bibliographic Details
Published inJournal of neuropathology and experimental neurology Vol. 72; no. 2; pp. 130 - 136
Main Authors Beach, Thomas G., Adler, Charles H., Dugger, Brittany N., Serrano, Geidy, Hidalgo, Jose, Henry-Watson, Jonette, Shill, Holly A., Sue, Lucia I., Sabbagh, Marwan N., Akiyama, Haruhiko
Format Journal Article
LanguageEnglish
Published England American Association of Neuropathologists, Inc 01.02.2013
Oxford University Press
Subjects
Online AccessGet full text
ISSN0022-3069
1554-6578
1554-6578
DOI10.1097/NEN.0b013e3182805c72

Cover

Loading…
Abstract ABSTRACTThe clinical diagnosis of Parkinson disease (PD) is incorrect in 30% or more of subjects particularly at the time of symptom onset. Because Lewy-type α-synucleinopathy is present in the submandibular glands of PD patients, we assessed the feasibility of submandibular gland biopsy for diagnosing PD. We performed immunohistochemical staining for Lewy-type α-synucleinopathy in sections of large segments (simulating open biopsy) and needle cores of submandibular glands from 128 autopsied and neuropathologically classified subjects, including 28 PD, 5 incidental Lewy body disease, 5 progressive supranuclear palsy (3 with concurrent PD), 3 corticobasal degeneration, 2 multiple system atrophy, 22 Alzheimer disease with Lewy bodies, 16 Alzheimer disease without Lewy bodies, and 50 normal elderly. Immunoreactive nerve fibers were present in large submandibular gland sections of all 28 PD subjects (including 3 that also had progressive supranuclear palsy); 3 Alzheimer disease with Lewy bodies subjects were also positive, but none of the other subjects were positive. Cores from frozen submandibular glands taken with 18-gauge needles (total length, 15–38 mm; between 10 and 118 sections per subject examined) were positive for Lewy-type α-synucleinopathy in 17 of 19 PD patients. These results suggest that biopsy of the submandibular gland may be a feasible means of improving PD clinical diagnostic accuracy. This would be particularly advantageous for subject selection in early-stage clinical trials for invasive therapies or for verifying other biomarker studies.
AbstractList The clinical diagnosis of Parkinson disease (PD) is incorrect in 30% or more of subjects particularly at the time of symptom onset. Because Lewy-type α-synucleinopathy is present in the submandibular glands of PD patients, we assessed the feasibility of submandibular gland biopsy for diagnosing PD. We performed immunohistochemical staining for Lewy-type α-synucleinopathy in sections of large segments (simulating open biopsy) and needle cores of submandibular glands from 128 autopsied and neuropathologically classified subjects, including 28 PD, 5 incidental Lewy body disease, 5 progressive supranuclear palsy (3 with concurrent PD), 3 corticobasal degeneration, 2 multiple system atrophy, 22 Alzheimer disease with Lewy bodies, 16 Alzheimer disease without Lewy bodies, and 50 normal elderly. Immunoreactive nerve fibers were present in large submandibular gland sections of all 28 PD subjects (including 3 that also had progressive supranuclear palsy); 3 Alzheimer disease with Lewy bodies subjects were also positive, but none of the other subjects were positive. Cores from frozen submandibular glands taken with 18-gauge needles (total length, 15-38 mm; between 10 and 118 sections per subject examined) were positive for Lewy-type α-synucleinopathy in 17 of 19 PD patients. These results suggest that biopsy of the submandibular gland may be a feasible means of improving PD clinical diagnostic accuracy. This would be particularly advantageous for subject selection in early-stage clinical trials for invasive therapies or for verifying other biomarker studies.The clinical diagnosis of Parkinson disease (PD) is incorrect in 30% or more of subjects particularly at the time of symptom onset. Because Lewy-type α-synucleinopathy is present in the submandibular glands of PD patients, we assessed the feasibility of submandibular gland biopsy for diagnosing PD. We performed immunohistochemical staining for Lewy-type α-synucleinopathy in sections of large segments (simulating open biopsy) and needle cores of submandibular glands from 128 autopsied and neuropathologically classified subjects, including 28 PD, 5 incidental Lewy body disease, 5 progressive supranuclear palsy (3 with concurrent PD), 3 corticobasal degeneration, 2 multiple system atrophy, 22 Alzheimer disease with Lewy bodies, 16 Alzheimer disease without Lewy bodies, and 50 normal elderly. Immunoreactive nerve fibers were present in large submandibular gland sections of all 28 PD subjects (including 3 that also had progressive supranuclear palsy); 3 Alzheimer disease with Lewy bodies subjects were also positive, but none of the other subjects were positive. Cores from frozen submandibular glands taken with 18-gauge needles (total length, 15-38 mm; between 10 and 118 sections per subject examined) were positive for Lewy-type α-synucleinopathy in 17 of 19 PD patients. These results suggest that biopsy of the submandibular gland may be a feasible means of improving PD clinical diagnostic accuracy. This would be particularly advantageous for subject selection in early-stage clinical trials for invasive therapies or for verifying other biomarker studies.
The clinical diagnosis of Parkinson disease (PD) is incorrect in 30% or more of subjects particularly at the time of symptom onset. Because Lewy-type alpha -synucleinopathy is present in the submandibular glands of PD patients, we assessed the feasibility of submandibular gland biopsy for diagnosing PD. We performed immunohistochemical staining for Lewy-type alpha -synucleinopathy in sections of large segments (simulating open biopsy) and needle cores of submandibular glands from 128 autopsied and neuropathologically classified subjects, including 28 PD, 5 incidental Lewy body disease, 5 progressive supranuclear palsy (3 with concurrent PD), 3 corticobasal degeneration, 2 multiple system atrophy, 22 Alzheimer disease with Lewy bodies, 16 Alzheimer disease without Lewy bodies, and 50 normal elderly. Immunoreactive nerve fibers were present in large submandibular gland sections of all 28 PD subjects (including 3 that also had progressive supranuclear palsy); 3 Alzheimer disease with Lewy bodies subjects were also positive, but none of the other subjects were positive. Cores from frozen submandibular glands taken with 18-gauge needles (total length, 15-38 mm; between 10 and 118 sections per subject examined) were positive for Lewy-type alpha -synucleinopathy in 17 of 19 PD patients. These results suggest that biopsy of the submandibular gland may be a feasible means of improving PD clinical diagnostic accuracy. This would be particularly advantageous for subject selection in early-stage clinical trials for invasive therapies or for verifying other biomarker studies.
ABSTRACTThe clinical diagnosis of Parkinson disease (PD) is incorrect in 30% or more of subjects particularly at the time of symptom onset. Because Lewy-type α-synucleinopathy is present in the submandibular glands of PD patients, we assessed the feasibility of submandibular gland biopsy for diagnosing PD. We performed immunohistochemical staining for Lewy-type α-synucleinopathy in sections of large segments (simulating open biopsy) and needle cores of submandibular glands from 128 autopsied and neuropathologically classified subjects, including 28 PD, 5 incidental Lewy body disease, 5 progressive supranuclear palsy (3 with concurrent PD), 3 corticobasal degeneration, 2 multiple system atrophy, 22 Alzheimer disease with Lewy bodies, 16 Alzheimer disease without Lewy bodies, and 50 normal elderly. Immunoreactive nerve fibers were present in large submandibular gland sections of all 28 PD subjects (including 3 that also had progressive supranuclear palsy); 3 Alzheimer disease with Lewy bodies subjects were also positive, but none of the other subjects were positive. Cores from frozen submandibular glands taken with 18-gauge needles (total length, 15–38 mm; between 10 and 118 sections per subject examined) were positive for Lewy-type α-synucleinopathy in 17 of 19 PD patients. These results suggest that biopsy of the submandibular gland may be a feasible means of improving PD clinical diagnostic accuracy. This would be particularly advantageous for subject selection in early-stage clinical trials for invasive therapies or for verifying other biomarker studies.
The clinical diagnosis of Parkinson disease (PD) is incorrect in 30% or more of subjects particularly at the time of symptom onset. Because Lewy-type α-synucleinopathy is present in the submandibular glands of PD patients, we assessed the feasibility of submandibular gland biopsy for diagnosing PD. We performed immunohistochemical staining for Lewy-type α-synucleinopathy in sections of large segments (simulating open biopsy) and needle cores of submandibular glands from 128 autopsied and neuropathologically classified subjects, including 28 PD, 5 incidental Lewy body disease, 5 progressive supranuclear palsy (3 with concurrent PD), 3 corticobasal degeneration, 2 multiple system atrophy, 22 Alzheimer disease with Lewy bodies, 16 Alzheimer disease without Lewy bodies, and 50 normal elderly. Immunoreactive nerve fibers were present in large submandibular gland sections of all 28 PD subjects (including 3 that also had progressive supranuclear palsy); 3 Alzheimer disease with Lewy bodies subjects were also positive, but none of the other subjects were positive. Cores from frozen submandibular glands taken with 18-gauge needles (total length, 15-38 mm; between 10 and 118 sections per subject examined) were positive for Lewy-type α-synucleinopathy in 17 of 19 PD patients. These results suggest that biopsy of the submandibular gland may be a feasible means of improving PD clinical diagnostic accuracy. This would be particularly advantageous for subject selection in early-stage clinical trials for invasive therapies or for verifying other biomarker studies.
The clinical diagnosis of Parkinson disease (PD) is incorrect in 30% or more of subjects, particularly at the time of symptom onset. Because Lewy-type α-synucleinopathy (LTS) is present in the submandibular glands of PD patients, we assessed the feasibility of submandibular gland biopsy for diagnosing PD. We performed immunohistochemical staining for LTS in sections of large segments (simulating open biopsy) and needle cores of submandibular gland from 128 autopsied and neuropathologically classified subjects, including 28 PD, 5 incidental Lewy body disease, 5 progressive supranuclear palsy ([PSP] 3 with concurrent PD), 3 corticobasal degeneration, 2 multiple system atrophy, 22 Alzheimer disease with Lewy bodies (ADLB), 16 Alzheimer disease without Lewy bodies and 50 normal elderly. Immunoreactive nerve fibers were present in large submandibular gland sections of all 28 PD subjects (including 3 that also had PSP); 3 ADLB subjects were also positive, but none of the other subjects were positive. Cores from frozen submandibular glands taken with 18 gauge needles (total length 15–38 mm, between 10 and 118 sections per subject examined) were positive for LTS in 17 of 19 PD patients. These results suggest that biopsy of the submandibular gland may be a feasible means of improving PD clinical diagnostic accuracy. This would be particularly advantageous for subject selection in early-stage clinical trials, for invasive therapies or for verifying other biomarker studies.
The clinical diagnosis of Parkinson disease (PD) is incorrect in 30% or more of subjects particularly at the time of symptom onset. Because Lewy-type α-synucleinopathy is present in the submandibular glands of PD patients, we assessed the feasibility of submandibular gland biopsy for diagnosing PD. We performed immunohistochemical staining for Lewy-type α-synucleinopathy in sections of large segments (simulating open biopsy) and needle cores of submandibular glands from 128 autopsied and neuropathologically classified subjects, including 28 PD, 5 incidental Lewy body disease, 5 progressive supranuclear palsy (3 with concurrent PD), 3 corticobasal degeneration, 2 multiple system atrophy, 22 Alzheimer disease with Lewy bodies, 16 Alzheimer disease without Lewy bodies, and 50 normal elderly. Immunoreactive nerve fibers were present in large submandibular gland sections of all 28 PD subjects (including 3 that also had progressive supranuclear palsy); 3 Alzheimer disease with Lewy bodies subjects were also positive, but none of the other subjects were positive. Cores from frozen submandibular glands taken with 18-gauge needles (total length, 15-38 mm; between 10 and 118 sections per subject examined) were positive for Lewy-type α-synucleinopathy in 17 of 19 PD patients. These results suggest that biopsy of the submandibular gland may be a feasible means of improving PD clinical diagnostic accuracy. This would be particularly advantageous for subject selection in early-stage clinical trials for invasive therapies or for verifying other biomarker studies. [PUBLICATION ABSTRACT]
Author Shill, Holly A.
Dugger, Brittany N.
Sue, Lucia I.
Akiyama, Haruhiko
Hidalgo, Jose
Beach, Thomas G.
Serrano, Geidy
Henry-Watson, Jonette
Sabbagh, Marwan N.
Adler, Charles H.
AuthorAffiliation From the Banner Sun Health Research Institute, Sun City, Arizona (TGB, BND, GS, JH, JH-W, HAS, LIS, MNS); Mayo Clinic, Scottsdale, Arizona (CHA); and Tokyo Institute of Psychiatry, Tokyo, Japan (HA)
AuthorAffiliation_xml – name: From the Banner Sun Health Research Institute, Sun City, Arizona (TGB, BND, GS, JH, JH-W, HAS, LIS, MNS); Mayo Clinic, Scottsdale, Arizona (CHA); and Tokyo Institute of Psychiatry, Tokyo, Japan (HA)
– name: 1 Banner Sun Health Research Institute, Sun City, Arizona
– name: 2 Mayo Clinic, Scottsdale, Arizona
– name: 3 Tokyo Institute of Psychiatry, Tokyo, Japan
Author_xml – sequence: 1
  givenname: Thomas
  surname: Beach
  middlename: G.
  fullname: Beach, Thomas G.
  organization: From the Banner Sun Health Research Institute, Sun City, Arizona (TGB, BND, GS, JH, JH-W, HAS, LIS, MNS); Mayo Clinic, Scottsdale, Arizona (CHA); and Tokyo Institute of Psychiatry, Tokyo, Japan (HA)
– sequence: 2
  givenname: Charles
  surname: Adler
  middlename: H.
  fullname: Adler, Charles H.
– sequence: 3
  givenname: Brittany
  surname: Dugger
  middlename: N.
  fullname: Dugger, Brittany N.
– sequence: 4
  givenname: Geidy
  surname: Serrano
  fullname: Serrano, Geidy
– sequence: 5
  givenname: Jose
  surname: Hidalgo
  fullname: Hidalgo, Jose
– sequence: 6
  givenname: Jonette
  surname: Henry-Watson
  fullname: Henry-Watson, Jonette
– sequence: 7
  givenname: Holly
  surname: Shill
  middlename: A.
  fullname: Shill, Holly A.
– sequence: 8
  givenname: Lucia
  surname: Sue
  middlename: I.
  fullname: Sue, Lucia I.
– sequence: 9
  givenname: Marwan
  surname: Sabbagh
  middlename: N.
  fullname: Sabbagh, Marwan N.
– sequence: 10
  givenname: Haruhiko
  surname: Akiyama
  fullname: Akiyama, Haruhiko
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23334596$$D View this record in MEDLINE/PubMed
BookMark eNqFUtFuFCEUJabGblf_wJhJfPFl6oULzOCDSa21mjTVRH0mzABd2tlhhRmb_r1suja6L30CLuece7iHI3IwxtER8pLCMQXVvL08uzyGDig6pC1rQfQNe0IWVAheS9G0B2QBwFiNINUhOcr5GgAUKP6MHDJE5ELJBTn5PndrM9rQzYNJ1flQ9tWHEDf5rvIxVdPKVR-DuRpjDrmKvvpm0k0YcxxLOTuT3XPy1Jshuxe7dUl-fjr7cfq5vvh6_uX05KLuRQuyNswKoailnULG2w6htYp3jIJpwFPrBOOd9F623PkeUVjbSKt8h6rrvbO4JO_vdTfFsbO9G6dkBr1JYW3SnY4m6P9vxrDSV_G3RtFQibQIvNkJpPhrdnnS65B7N5QnuzhnTVE2XHEU-DiUtYJL3kpRoK_3oNdxTmOZRBGkokEhSvclefWv-QfXf4MoAH4P6FPMOTn_AKGgt3nrkrfez7vQ3u3R-jCZKcTtCMLwGHnX8zYOk0v5ZphvXdIrZ4ZppctvAQENq1mhASuneluS-Ad3tr9b
CODEN JNENAD
CitedBy_id crossref_primary_10_1515_revneuro_2018_0064
crossref_primary_10_3389_fnagi_2021_702639
crossref_primary_10_3390_ijms19113573
crossref_primary_10_1111_jnc_14809
crossref_primary_10_1111_neup_12189
crossref_primary_10_1097_MD_0000000000030079
crossref_primary_10_1586_14737175_2014_877842
crossref_primary_10_3233_JPD_150680
crossref_primary_10_1007_s00401_014_1284_0
crossref_primary_10_1111_ene_13395
crossref_primary_10_3233_JPD_212733
crossref_primary_10_1002_mds_27907
crossref_primary_10_1101_cshperspect_a023630
crossref_primary_10_1007_s00455_024_10693_3
crossref_primary_10_1371_journal_pone_0231720
crossref_primary_10_17816_rmmar83635
crossref_primary_10_1016_j_parkreldis_2017_02_031
crossref_primary_10_1016_j_neurobiolaging_2013_08_008
crossref_primary_10_3390_antiox10050715
crossref_primary_10_1016_j_lfs_2020_118976
crossref_primary_10_3233_JPD_202489
crossref_primary_10_1007_s00401_013_1214_6
crossref_primary_10_1007_s11910_015_0607_4
crossref_primary_10_1016_j_trac_2023_116922
crossref_primary_10_1586_14737175_2015_1083423
crossref_primary_10_1093_brain_awv138
crossref_primary_10_1016_j_neuint_2013_06_005
crossref_primary_10_1080_15622975_2017_1375556
crossref_primary_10_1007_s00415_023_11893_x
crossref_primary_10_1017_S1355617716000503
crossref_primary_10_1111_ene_12753
crossref_primary_10_1002_acn3_285
crossref_primary_10_1002_j_2769_2795_2017_tb00012_x
crossref_primary_10_1016_S1474_4422_16_00080_6
crossref_primary_10_1093_jnen_nlw103
crossref_primary_10_1016_S1474_4422_15_00007_1
crossref_primary_10_1007_s00415_022_11267_9
crossref_primary_10_3390_genes13101715
crossref_primary_10_3390_brainsci11050661
crossref_primary_10_1111_jnc_14330
crossref_primary_10_1016_j_parkreldis_2018_04_019
crossref_primary_10_1136_jnnp_2015_311890
crossref_primary_10_3389_fneur_2021_661117
crossref_primary_10_1016_j_smrv_2020_101283
crossref_primary_10_1038_nrneurol_2014_263
crossref_primary_10_1002_mds_25596
crossref_primary_10_1111_ane_12247
crossref_primary_10_1007_s10072_015_2190_5
crossref_primary_10_1016_j_neulet_2013_07_016
crossref_primary_10_1016_j_pathol_2024_10_006
crossref_primary_10_1016_j_parkreldis_2016_10_011
crossref_primary_10_1002_mds_26480
crossref_primary_10_1080_10408363_2019_1711359
crossref_primary_10_3748_wjg_v22_i25_5742
crossref_primary_10_1016_j_baga_2015_05_001
crossref_primary_10_1084_jem_20150656
crossref_primary_10_1002_mds_25467
crossref_primary_10_1111_nmo_12797
crossref_primary_10_1007_s00441_018_2851_9
crossref_primary_10_1007_s00401_024_02781_3
crossref_primary_10_1093_jnen_nlz080
crossref_primary_10_1111_odi_12463
crossref_primary_10_1021_acschemneuro_8b00383
crossref_primary_10_1212_WNL_0000000000000641
crossref_primary_10_3348_kjr_2023_0066
crossref_primary_10_1002_mds_26476
crossref_primary_10_1097_NEN_0000000000000137
crossref_primary_10_1212_WNL_0000000000000204
crossref_primary_10_1111_neup_12691
crossref_primary_10_3390_biom13081263
crossref_primary_10_1016_j_jocn_2019_05_033
crossref_primary_10_1074_jbc_M116_744029
crossref_primary_10_1111_neup_12772
crossref_primary_10_1212_WNL_0000000000001240
crossref_primary_10_1016_j_neulet_2024_137702
crossref_primary_10_3233_JPD_230154
crossref_primary_10_3390_ijms17020189
crossref_primary_10_1016_j_trprot_2014_08_001
crossref_primary_10_1016_j_neulet_2014_04_027
crossref_primary_10_3233_JAD_150859
crossref_primary_10_1016_j_parkreldis_2019_10_006
crossref_primary_10_1111_ncn3_12596
crossref_primary_10_1111_bpa_12370
crossref_primary_10_1007_s00455_015_9612_7
crossref_primary_10_1093_jnen_nlad022
crossref_primary_10_1007_s00702_013_1038_5
crossref_primary_10_1136_jclinpath_2019_205952
crossref_primary_10_1212_CPJ_0000000000001016
crossref_primary_10_2217_bmm_2016_0366
crossref_primary_10_1002_mds_28242
crossref_primary_10_3389_fnins_2017_00114
Cites_doi 10.1371/journal.pone.0012728
10.1002/1097-0142(20001225)90:6<350::AID-CNCR5>3.0.CO;2-E
10.1136/jnnp.2008.144501
10.1212/WNL.57.8.1497
10.1002/mds.23838
10.1136/jnnp.55.3.181
10.1097/NRL.0b013e318095a4d5
10.1016/S0733-8619(18)30215-9
10.1007/s00401-010-0665-2
10.1001/archneur.55.7.969
10.1002/ana.410170406
10.1001/archneur.56.1.33
10.1007/s00701-007-1267-1
10.1002/mds.20955
10.1007/s00401-004-0950-z
10.1038/ncb748
10.1080/02688690601012175
10.1136/gut.2008.162503
10.1097/62.3.237
10.1111/j.1365-2982.2012.01887.x
10.1007/s00401-008-0409-8
10.1016/S0197-4580(97)00057-2
10.1679/aohc.52.Suppl_191
10.1016/j.parkreldis.2012.04.020
10.1016/S0304-3940(99)00411-5
10.1212/01.wnl.0000187889.17253.b1
10.1007/BF00687767
10.1212/01.wnl.0000264429.59379.d9
10.1212/WNL.44.6.1015
10.1002/mds.25020
10.1007/s00401-009-0538-8
10.1007/s00401-007-0313-7
10.1111/j.1750-3639.2012.00585.x
10.1007/s10561-008-9067-2
10.1227/01.NEU.0000285347.50028.B9
10.1001/jama.2010.2008
10.1007/s00401-009-0527-y
10.1093/brain/124.7.1438
10.1016/j.parkreldis.2011.02.017
10.1007/s00401-009-0629-6
10.1006/brcg.1995.1261
10.1001/archneur.65.8.1074
10.1016/j.neulet.2005.11.012
10.1007/BF00294234
10.1136/jme.2005.013169
10.1017/S0317167100031814
10.1002/mds.23344
10.1055/s-2001-13125
10.1007/s00401-010-0664-3
10.1007/s00401-008-0345-7
10.1002/mds.10211
10.1007/s00401-012-1040-2
ContentType Journal Article
Copyright 2013 American Association of Neuropathologists, Inc
Copyright Lippincott Williams & Wilkins Feb 2013
Copyright_xml – notice: 2013 American Association of Neuropathologists, Inc
– notice: Copyright Lippincott Williams & Wilkins Feb 2013
CorporateAuthor Arizona Parkinson's Disease Consortium
Arizona Parkinson’s Disease Consortium
CorporateAuthor_xml – name: Arizona Parkinson's Disease Consortium
– name: Arizona Parkinson’s Disease Consortium
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
88G
88I
8AF
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
M0S
M1P
M2P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
Q9U
S0X
7X8
7TK
5PM
DOI 10.1097/NEN.0b013e3182805c72
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Psychology Database (Alumni)
Science Database (Alumni Edition)
STEM Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Health & Medical Collection
Medical Database
Science Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
SIRS Editorial
MEDLINE - Academic
Neurosciences Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
SIRS Editorial
ProQuest Health & Medical Complete (Alumni)
ProQuest AP Science
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Psychology Journals (Alumni)
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList MEDLINE - Academic
Neurosciences Abstracts

MEDLINE

ProQuest Central Student
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1554-6578
EndPage 136
ExternalDocumentID PMC3571631
2913067271
23334596
10_1097_NEN_0b013e3182805c72
00005072-201302000-00006
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NINDS NIH HHS
  grantid: U24 NS072026
– fundername: NIA NIH HHS
  grantid: P30 AG019610
– fundername: NIA NIH HHS
  grantid: P30 AG19610
– fundername: National Institute of Neurological Disorders and Stroke : NINDS
  grantid: U24 NS072026 || NS
– fundername: National Institute on Aging : NIA
  grantid: P30 AG019610 || AG
GroupedDBID ---
.55
.GJ
.Z2
01R
0R~
1TH
29L
3O-
40H
48X
5GY
5RE
5VS
5WD
71W
77Y
7O~
7X7
88E
88I
8AF
8FI
8FJ
8R4
8R5
AABZA
AACZT
AAIMJ
AAJQQ
AAKAS
AAMDB
AAMVS
AAPGJ
AAPQZ
AAPXW
AARHZ
AASOK
AAUAY
AAUQX
AAVAP
AAWDT
ABBUW
ABDFA
ABEJV
ABEUO
ABGNP
ABIVO
ABIXL
ABJNI
ABLJU
ABMNT
ABNHQ
ABPQP
ABPTD
ABQNK
ABSMQ
ABUWG
ABVGC
ABWST
ABXVV
ABXZS
ABZAD
ACCCW
ACDDN
ACFRR
ACGFO
ACGFS
ACGOD
ACUFI
ACUTJ
ACVCV
ACWDW
ACWRI
ACZBC
ADBBV
ADBIZ
ADFPA
ADGKP
ADGZP
ADHKW
ADIPN
ADMTO
ADNBA
ADQBN
ADRTK
ADVEK
ADZCM
AE3
AELWJ
AEMDU
AEMQT
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFNX
AFFQV
AFFZL
AFGWE
AFIYH
AFKRA
AFOFC
AFTRI
AFUWQ
AFXAL
AFYAG
AGINI
AGINJ
AGKRT
AGMDO
AGORE
AGQXC
AGSYK
AGUTN
AHGBF
AHMBA
AHMMS
AHRYX
AHVBC
AI.
AIZYK
AJBYB
AJDVS
AJEEA
AJNCP
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALUQC
ALXQX
APIBT
APJGH
AQDSO
AQKUS
ARIXL
ATGXG
AVNTJ
AVWKF
AYOIW
AZQEC
BAYMD
BCRHZ
BENPR
BHONS
BOYCO
BPHCQ
BQDIO
BS7
BSWAC
BTRTY
BVRKM
BVXVI
BZKNY
C45
CCPQU
CDBKE
CS3
DAKXR
DILTD
DU5
DWQXO
E.X
EBS
EIHJH
EJD
ENERS
EX3
F2K
F2L
F2M
F2N
F5P
FECEO
FHSFR
FL-
FLUFQ
FOEOM
FOTVD
FQBLK
FW0
FYUFA
GAUVT
GJXCC
GNUQQ
H0~
H13
HCIFZ
HMCUK
HZ~
IAO
IHR
INH
IN~
ITC
J21
JK3
JK8
JXSIZ
K8S
KBUDW
KD2
KMI
KOP
KQ8
KSI
KSN
L7B
M1P
M2M
M2P
M2Q
MBLQV
MHKGH
N9A
NLBLG
NOMLY
NOYVH
NVLIB
N~7
N~B
N~M
OAUYM
OAWHX
OBFPC
OBOKY
OCUKA
OCZFY
ODA
ODMLO
OJQWA
OJZSN
OK1
OLG
OLH
OLV
OLZ
OPAEJ
ORVUJ
OVD
OWPYF
P-K
P2P
PAFKI
PEELM
PHGZM
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
R58
ROX
ROZ
RUSNO
RWL
S0X
S4R
S4S
TAE
TEORI
TLC
TMA
UKHRP
V2I
VH1
W3M
WH7
WOQ
WOW
X3V
X3W
X7M
XJT
YAYTL
YKOAZ
YXANX
ZGI
ZXP
ZY1
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
NU-
PJZUB
PPXIY
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
PUEGO
Q9U
7X8
7TK
5PM
ID FETCH-LOGICAL-c5806-a2d5591d1b93248b308d94b210a70f1de524b6ff684efc335dd76d9fb39bcfed3
IEDL.DBID 7X7
ISSN 0022-3069
1554-6578
IngestDate Thu Aug 21 14:16:12 EDT 2025
Tue Aug 05 11:03:48 EDT 2025
Fri Jul 11 04:26:27 EDT 2025
Mon Sep 01 03:11:36 EDT 2025
Mon Jul 21 05:52:28 EDT 2025
Thu Apr 24 23:00:09 EDT 2025
Tue Jul 01 03:11:19 EDT 2025
Fri May 16 04:03:52 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5806-a2d5591d1b93248b308d94b210a70f1de524b6ff684efc335dd76d9fb39bcfed3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://academic.oup.com/jnen/article-pdf/72/2/130/9562462/72-2-130.pdf
PMID 23334596
PQID 1315735516
PQPubID 40718
PageCount 7
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3571631
proquest_miscellaneous_1367494353
proquest_miscellaneous_1285464865
proquest_journals_1315735516
pubmed_primary_23334596
crossref_primary_10_1097_NEN_0b013e3182805c72
crossref_citationtrail_10_1097_NEN_0b013e3182805c72
wolterskluwer_health_00005072-201302000-00006
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2013-February
2013-02-00
2013-Feb
20130201
PublicationDateYYYYMMDD 2013-02-01
PublicationDate_xml – month: 02
  year: 2013
  text: 2013-February
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: Cary
PublicationTitle Journal of neuropathology and experimental neurology
PublicationTitleAlternate J Neuropathol Exp Neurol
PublicationYear 2013
Publisher American Association of Neuropathologists, Inc
Oxford University Press
Publisher_xml – name: American Association of Neuropathologists, Inc
– name: Oxford University Press
References 2016030323445486000_72.2.130.46
2016030323445486000_72.2.130.45
2016030323445486000_72.2.130.44
2016030323445486000_72.2.130.43
2016030323445486000_72.2.130.49
2016030323445486000_72.2.130.48
2016030323445486000_72.2.130.42
2016030323445486000_72.2.130.41
2016030323445486000_72.2.130.40
Munoz (2016030323445486000_72.2.130.47) 2008; 67
Gibb (2016030323445486000_72.2.130.8) 1992; 10
Rajput (2016030323445486000_72.2.130.2) 1991; 18
2016030323445486000_72.2.130.13
2016030323445486000_72.2.130.12
2016030323445486000_72.2.130.56
2016030323445486000_72.2.130.11
2016030323445486000_72.2.130.55
2016030323445486000_72.2.130.10
2016030323445486000_72.2.130.54
2016030323445486000_72.2.130.17
2016030323445486000_72.2.130.16
2016030323445486000_72.2.130.14
Gill (2016030323445486000_72.2.130.15) 2007; 100
2016030323445486000_72.2.130.53
2016030323445486000_72.2.130.52
2016030323445486000_72.2.130.51
2016030323445486000_72.2.130.50
Obeso (2016030323445486000_72.2.130.9) 1997; 6
2016030323445486000_72.2.130.19
Wakabayashi (2016030323445486000_72.2.130.28) 1989; 52
Ceuterick-de Groote (2016030323445486000_72.2.130.18) 1998; 8
2016030323445486000_72.2.130.24
2016030323445486000_72.2.130.23
2016030323445486000_72.2.130.22
2016030323445486000_72.2.130.21
2016030323445486000_72.2.130.27
2016030323445486000_72.2.130.26
2016030323445486000_72.2.130.25
2016030323445486000_72.2.130.20
2016030323445486000_72.2.130.29
2016030323445486000_72.2.130.35
2016030323445486000_72.2.130.34
2016030323445486000_72.2.130.33
2016030323445486000_72.2.130.32
2016030323445486000_72.2.130.39
2016030323445486000_72.2.130.38
2016030323445486000_72.2.130.37
2016030323445486000_72.2.130.36
2016030323445486000_72.2.130.5
2016030323445486000_72.2.130.6
2016030323445486000_72.2.130.7
2016030323445486000_72.2.130.1
2016030323445486000_72.2.130.31
2016030323445486000_72.2.130.30
2016030323445486000_72.2.130.3
2016030323445486000_72.2.130.4
15645265 - Acta Neuropathol. 2005 Jan;109(1):14-24
20229352 - Acta Neuropathol. 2010 Jun;119(6):703-13
20037761 - Acta Neuropathol. 2010 Jun;119(6):715-22
18469029 - J Neurol Neurosurg Psychiatry. 2008 Nov;79(11):1202-7
18347928 - Cell Tissue Bank. 2008 Sep;9(3):229-45
18264713 - Acta Neuropathol. 2008 Apr;115(4):437-44
11408338 - Brain. 2001 Jul;124(Pt 7):1438-49
17762742 - Neurosurgery. 2007 Aug;61(2):297-304; discussion 304-5
22941241 - Acta Neuropathol. 2012 Nov;124(5):665-80
17848865 - Neurologist. 2007 Sep;13(5):253-60
10821633 - Neurosci Lett. 1999 Jul 2;269(1):13-6
9330978 - Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2
16810718 - Mov Disord. 2006 Jun;21 Suppl 14:S171-96
19399512 - Acta Neuropathol. 2009 Jun;117(6):613-34
16330147 - Neurosci Lett. 2006 Mar 20;396(1):67-72
22292943 - Neurogastroenterol Motil. 2012 Apr;24(4):e202-5
19360428 - Acta Neuropathol. 2009 Aug;118(2):271-301
2850698 - Acta Neuropathol. 1988;76(3):217-221
23720221 - Mov Disord. 2013 Jun;28(6):734
18695057 - Arch Neurol. 2008 Aug;65(8):1074-80
22560049 - Parkinsonism Relat Disord. 2012 Aug;18(7):893-5
20856865 - PLoS One. 2010;5(9):e12728
11346020 - Semin Neurol. 2001;21(1):103-15
17329391 - J Med Ethics. 2007 Mar;33(3):169-73
11673599 - Neurology. 2001 Oct 23;57(8):1497-9
9923759 - Arch Neurol. 1999 Jan;56(1):33-9
21245183 - JAMA. 2011 Jan 19;305(3):275-83
21420891 - Parkinsonism Relat Disord. 2011 Jun;17(5):365-71
12465065 - Mov Disord. 2002 Nov;17(6):1255-64
2554944 - Arch Histol Cytol. 1989;52 Suppl:191-4
11156518 - Cancer. 2000 Dec 25;90(6):350-6
9458171 - Brain Pathol. 1998 Jan;8(1):121-32
19022934 - Gut. 2008 Dec;57(12):1741-3
8546858 - Brain Cogn. 1995 Aug;28(3):321-41
17690838 - Acta Neurochir (Wien). 2007;149(9):867-75; discussion 876
17129876 - Br J Neurosurg. 2006 Oct;20(5):290-5
17548551 - Neurology. 2007 Jun 5;68(23):2012-8
17474384 - Tenn Med. 2007 Apr;100(4):45-7
8208392 - Neurology. 1994 Jun;44(6):1015-24
17985144 - Acta Neuropathol. 2008 Apr;115(4):445-51
11813001 - Nat Cell Biol. 2002 Feb;4(2):160-4
16237129 - Neurology. 2005 Dec 27;65(12):1863-72
4004154 - Ann Neurol. 1985 Apr;17(4):337-43
9678315 - Arch Neurol. 1998 Jul;55(7):969-78
1913360 - Can J Neurol Sci. 1991 Aug;18(3):275-8
18626651 - Acta Neuropathol. 2008 Sep;116(3):277-88
22550057 - Mov Disord. 2012 May;27(6):716-9
9426872 - Baillieres Clin Neurol. 1997 Apr;6(1):125-45
20306269 - Acta Neuropathol. 2010 Jun;119(6):689-702
20836135 - Mov Disord. 2011 Jan;26(1):188-90
22369130 - Brain Pathol. 2012 Nov;22(6):745-56
21766334 - Mov Disord. 2012 May;27(6):709-15
1972853 - Acta Neuropathol. 1990;79(6):581-3
1564476 - J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
1584179 - Neurol Clin. 1992 May;10(2):361-76
References_xml – ident: 2016030323445486000_72.2.130.21
  doi: 10.1371/journal.pone.0012728
– ident: 2016030323445486000_72.2.130.34
  doi: 10.1002/1097-0142(20001225)90:6<350::AID-CNCR5>3.0.CO;2-E
– ident: 2016030323445486000_72.2.130.1
  doi: 10.1136/jnnp.2008.144501
– ident: 2016030323445486000_72.2.130.3
  doi: 10.1212/WNL.57.8.1497
– ident: 2016030323445486000_72.2.130.20
  doi: 10.1002/mds.23838
– ident: 2016030323445486000_72.2.130.4
  doi: 10.1136/jnnp.55.3.181
– ident: 2016030323445486000_72.2.130.17
  doi: 10.1097/NRL.0b013e318095a4d5
– volume: 100
  start-page: 45
  year: 2007
  ident: 2016030323445486000_72.2.130.15
  article-title: Deep brain stimulation for Parkinson's disease: The Vanderbilt University Medical Center experience, 1998–2004
  publication-title: Tenn Med
– volume: 10
  start-page: 361
  year: 1992
  ident: 2016030323445486000_72.2.130.8
  article-title: Neuropathology of Parkinson's disease and related syndromes
  publication-title: Neurol Clin
  doi: 10.1016/S0733-8619(18)30215-9
– ident: 2016030323445486000_72.2.130.30
  doi: 10.1007/s00401-010-0665-2
– ident: 2016030323445486000_72.2.130.7
  doi: 10.1001/archneur.55.7.969
– ident: 2016030323445486000_72.2.130.52
  doi: 10.1002/ana.410170406
– ident: 2016030323445486000_72.2.130.5
  doi: 10.1001/archneur.56.1.33
– ident: 2016030323445486000_72.2.130.16
  doi: 10.1007/s00701-007-1267-1
– ident: 2016030323445486000_72.2.130.13
  doi: 10.1002/mds.20955
– ident: 2016030323445486000_72.2.130.38
  doi: 10.1007/s00401-004-0950-z
– ident: 2016030323445486000_72.2.130.41
  doi: 10.1038/ncb748
– ident: 2016030323445486000_72.2.130.12
  doi: 10.1080/02688690601012175
– ident: 2016030323445486000_72.2.130.22
  doi: 10.1136/gut.2008.162503
– ident: 2016030323445486000_72.2.130.45
  doi: 10.1097/62.3.237
– ident: 2016030323445486000_72.2.130.24
  doi: 10.1111/j.1365-2982.2012.01887.x
– ident: 2016030323445486000_72.2.130.35
  doi: 10.1007/s00401-008-0409-8
– ident: 2016030323445486000_72.2.130.39
  doi: 10.1016/S0197-4580(97)00057-2
– volume: 52
  start-page: 191
  year: 1989
  ident: 2016030323445486000_72.2.130.28
  article-title: Lewy bodies in the enteric nervous system in Parkinson's disease
  publication-title: Arch Histol Cytol
  doi: 10.1679/aohc.52.Suppl_191
– ident: 2016030323445486000_72.2.130.23
  doi: 10.1016/j.parkreldis.2012.04.020
– ident: 2016030323445486000_72.2.130.42
  doi: 10.1016/S0304-3940(99)00411-5
– ident: 2016030323445486000_72.2.130.40
  doi: 10.1212/01.wnl.0000187889.17253.b1
– ident: 2016030323445486000_72.2.130.27
  doi: 10.1007/BF00687767
– ident: 2016030323445486000_72.2.130.46
  doi: 10.1212/01.wnl.0000264429.59379.d9
– ident: 2016030323445486000_72.2.130.53
  doi: 10.1212/WNL.44.6.1015
– ident: 2016030323445486000_72.2.130.19
  doi: 10.1002/mds.25020
– volume: 67
  start-page: 489
  year: 2008
  ident: 2016030323445486000_72.2.130.47
  article-title: Expression of alpha-synuclein (AS) in autonomic neurons is increased in Parkinson's disease (PD) [Abstract]
  publication-title: J Neuropathol Exp Neurol
– ident: 2016030323445486000_72.2.130.36
  doi: 10.1007/s00401-009-0538-8
– ident: 2016030323445486000_72.2.130.31
  doi: 10.1007/s00401-007-0313-7
– ident: 2016030323445486000_72.2.130.44
  doi: 10.1111/j.1750-3639.2012.00585.x
– ident: 2016030323445486000_72.2.130.37
  doi: 10.1007/s10561-008-9067-2
– ident: 2016030323445486000_72.2.130.14
  doi: 10.1227/01.NEU.0000285347.50028.B9
– ident: 2016030323445486000_72.2.130.55
  doi: 10.1001/jama.2010.2008
– ident: 2016030323445486000_72.2.130.56
  doi: 10.1007/s00401-009-0527-y
– ident: 2016030323445486000_72.2.130.51
  doi: 10.1093/brain/124.7.1438
– ident: 2016030323445486000_72.2.130.50
  doi: 10.1016/j.parkreldis.2011.02.017
– ident: 2016030323445486000_72.2.130.48
  doi: 10.1007/s00401-009-0629-6
– ident: 2016030323445486000_72.2.130.6
  doi: 10.1006/brcg.1995.1261
– ident: 2016030323445486000_72.2.130.33
  doi: 10.1001/archneur.65.8.1074
– ident: 2016030323445486000_72.2.130.49
  doi: 10.1016/j.neulet.2005.11.012
– ident: 2016030323445486000_72.2.130.29
  doi: 10.1007/BF00294234
– ident: 2016030323445486000_72.2.130.11
  doi: 10.1136/jme.2005.013169
– volume: 18
  start-page: 275
  year: 1991
  ident: 2016030323445486000_72.2.130.2
  article-title: Accuracy of clinical diagnosis in parkinsonism—A prospective study
  publication-title: Can J Neurol Sci
  doi: 10.1017/S0317167100031814
– ident: 2016030323445486000_72.2.130.25
  doi: 10.1002/mds.23344
– ident: 2016030323445486000_72.2.130.10
  doi: 10.1055/s-2001-13125
– ident: 2016030323445486000_72.2.130.26
  doi: 10.1007/s00401-010-0664-3
– volume: 8
  start-page: 121
  year: 1998
  ident: 2016030323445486000_72.2.130.18
  article-title: Extracerebral biopsy in lysosomal and peroxisomal disorders
  publication-title: Ultrastructural findings. Brain Pathol
– volume: 6
  start-page: 125
  year: 1997
  ident: 2016030323445486000_72.2.130.9
  article-title: Surgical treatment of Parkinson's disease
  publication-title: Baillieres Clin Neurol
– ident: 2016030323445486000_72.2.130.32
  doi: 10.1007/s00401-008-0345-7
– ident: 2016030323445486000_72.2.130.54
  doi: 10.1002/mds.10211
– ident: 2016030323445486000_72.2.130.43
  doi: 10.1007/s00401-012-1040-2
– reference: 11408338 - Brain. 2001 Jul;124(Pt 7):1438-49
– reference: 10821633 - Neurosci Lett. 1999 Jul 2;269(1):13-6
– reference: 20037761 - Acta Neuropathol. 2010 Jun;119(6):715-22
– reference: 22292943 - Neurogastroenterol Motil. 2012 Apr;24(4):e202-5
– reference: 17762742 - Neurosurgery. 2007 Aug;61(2):297-304; discussion 304-5
– reference: 18695057 - Arch Neurol. 2008 Aug;65(8):1074-80
– reference: 20856865 - PLoS One. 2010;5(9):e12728
– reference: 1913360 - Can J Neurol Sci. 1991 Aug;18(3):275-8
– reference: 17548551 - Neurology. 2007 Jun 5;68(23):2012-8
– reference: 21245183 - JAMA. 2011 Jan 19;305(3):275-83
– reference: 18264713 - Acta Neuropathol. 2008 Apr;115(4):437-44
– reference: 11813001 - Nat Cell Biol. 2002 Feb;4(2):160-4
– reference: 2850698 - Acta Neuropathol. 1988;76(3):217-221
– reference: 12465065 - Mov Disord. 2002 Nov;17(6):1255-64
– reference: 1564476 - J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4
– reference: 1584179 - Neurol Clin. 1992 May;10(2):361-76
– reference: 17690838 - Acta Neurochir (Wien). 2007;149(9):867-75; discussion 876
– reference: 16237129 - Neurology. 2005 Dec 27;65(12):1863-72
– reference: 9330978 - Neurobiol Aging. 1997 Jul-Aug;18(4 Suppl):S1-2
– reference: 17848865 - Neurologist. 2007 Sep;13(5):253-60
– reference: 11673599 - Neurology. 2001 Oct 23;57(8):1497-9
– reference: 20306269 - Acta Neuropathol. 2010 Jun;119(6):689-702
– reference: 22560049 - Parkinsonism Relat Disord. 2012 Aug;18(7):893-5
– reference: 8208392 - Neurology. 1994 Jun;44(6):1015-24
– reference: 18469029 - J Neurol Neurosurg Psychiatry. 2008 Nov;79(11):1202-7
– reference: 16810718 - Mov Disord. 2006 Jun;21 Suppl 14:S171-96
– reference: 20836135 - Mov Disord. 2011 Jan;26(1):188-90
– reference: 18626651 - Acta Neuropathol. 2008 Sep;116(3):277-88
– reference: 2554944 - Arch Histol Cytol. 1989;52 Suppl:191-4
– reference: 22550057 - Mov Disord. 2012 May;27(6):716-9
– reference: 22369130 - Brain Pathol. 2012 Nov;22(6):745-56
– reference: 15645265 - Acta Neuropathol. 2005 Jan;109(1):14-24
– reference: 19022934 - Gut. 2008 Dec;57(12):1741-3
– reference: 9923759 - Arch Neurol. 1999 Jan;56(1):33-9
– reference: 16330147 - Neurosci Lett. 2006 Mar 20;396(1):67-72
– reference: 17329391 - J Med Ethics. 2007 Mar;33(3):169-73
– reference: 17985144 - Acta Neuropathol. 2008 Apr;115(4):445-51
– reference: 17129876 - Br J Neurosurg. 2006 Oct;20(5):290-5
– reference: 19360428 - Acta Neuropathol. 2009 Aug;118(2):271-301
– reference: 21766334 - Mov Disord. 2012 May;27(6):709-15
– reference: 8546858 - Brain Cogn. 1995 Aug;28(3):321-41
– reference: 22941241 - Acta Neuropathol. 2012 Nov;124(5):665-80
– reference: 17474384 - Tenn Med. 2007 Apr;100(4):45-7
– reference: 21420891 - Parkinsonism Relat Disord. 2011 Jun;17(5):365-71
– reference: 9458171 - Brain Pathol. 1998 Jan;8(1):121-32
– reference: 11346020 - Semin Neurol. 2001;21(1):103-15
– reference: 9426872 - Baillieres Clin Neurol. 1997 Apr;6(1):125-45
– reference: 9678315 - Arch Neurol. 1998 Jul;55(7):969-78
– reference: 1972853 - Acta Neuropathol. 1990;79(6):581-3
– reference: 23720221 - Mov Disord. 2013 Jun;28(6):734
– reference: 20229352 - Acta Neuropathol. 2010 Jun;119(6):703-13
– reference: 11156518 - Cancer. 2000 Dec 25;90(6):350-6
– reference: 18347928 - Cell Tissue Bank. 2008 Sep;9(3):229-45
– reference: 19399512 - Acta Neuropathol. 2009 Jun;117(6):613-34
– reference: 4004154 - Ann Neurol. 1985 Apr;17(4):337-43
SSID ssj0009094
Score 2.3982553
Snippet ABSTRACTThe clinical diagnosis of Parkinson disease (PD) is incorrect in 30% or more of subjects particularly at the time of symptom onset. Because Lewy-type...
The clinical diagnosis of Parkinson disease (PD) is incorrect in 30% or more of subjects particularly at the time of symptom onset. Because Lewy-type...
The clinical diagnosis of Parkinson disease (PD) is incorrect in 30% or more of subjects particularly at the time of symptom onset. Because Lewy-type alpha...
The clinical diagnosis of Parkinson disease (PD) is incorrect in 30% or more of subjects, particularly at the time of symptom onset. Because Lewy-type...
SourceID pubmedcentral
proquest
pubmed
crossref
wolterskluwer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 130
SubjectTerms Accuracy
Aged
Aged, 80 and over
alpha-Synuclein - metabolism
Biomarkers
Biopsy
Brain - pathology
Brain research
Clinical trials
Colon
Dementia
Feasibility studies
Female
Humans
Lewy Body Disease - pathology
Life sciences
Male
Medical research
Medical treatment
Multiple System Atrophy - pathology
Muscle, Smooth - pathology
Nerve Fibers - pathology
Parkinson Disease - metabolism
Parkinson Disease - pathology
Submandibular Gland - metabolism
Submandibular Gland - pathology
Supranuclear Palsy, Progressive - pathology
Title Submandibular Gland Biopsy for the Diagnosis of Parkinson Disease
URI https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00005072-201302000-00006
https://www.ncbi.nlm.nih.gov/pubmed/23334596
https://www.proquest.com/docview/1315735516
https://www.proquest.com/docview/1285464865
https://www.proquest.com/docview/1367494353
https://pubmed.ncbi.nlm.nih.gov/PMC3571631
Volume 72
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1ba9RAFB60BRGKeHe1lhF8DZ37ZJ7E6taidFGxsG8hk5nQRUm2pkX8956TTLKuhfqYzOQ6Z858Z75zIeR1BUswrusZgG-VqQB2Si5iyLzRXiqApGUfx326MCdn6uNSL9OGW5fcKked2Cvq0Fa4R37IJddWIq3zZn2RYdUoZFdTCY3bZBdTl6FLl13aTdJd5tSULZwZN4bOOXvYxGazByhypisrtpema3jzutvk3q8WKe3ue-_R_te6dHyf3EuAkr4dJOABuRWbh-TOaaLMH4HehLth7IpHh1P6AT0Z6dGqXXe_KQBWCgCQvh_87VYdbWuKcdB9SBic7smbx-TseP7t3UmW6iZklc6ZyUoRwE7ggXsAZyr3kuXBKQ_GXWlZzUPUQnlT1yZXsa6k1CFYE1ztpfNVHYN8QnaatonPCAWAwnnFg41gvUqvwRhRoD5LFp0QpSpnRI6_rKhSUnGsbfGjGMntxXxR_PujZySbrloPSTX-039_HI0iTbGu2AjEjLyammFyIONRNrG9gj4YH2pUbvQNfaSxyqHIzsjTYYCnlxJSSqUdPMFuDf3UAZNzb7c0q_M-SbfUYIlKDp-6JSTFEN6KnD8DKC5ASyF1nOL7mXl-86e-IHdFX48D_Wn2yc7lz6v4ElDRpT_oRf-A7B7NF5-_wtGnL_kfvcMIeg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VrQRICPFmoYCR4Bg18SvJASFKt2xpN0KolXpL49gRq1bJQlpV_VP8RmbyWpZK5dRr7DixxzP-xvMCeJfjEUznuofgW3rSop4ScWc9o5UREiFp1sRxzxI9PZRfj9TRGvzuY2HIrbKXiY2gtlVOd-SbgQhUKMis83Hx06OqUWRd7UtotNtiz11eoMpWf9jdRvq-53xncvB56nVVBbxcRag-Z9wiig5sYBC6yMgIP7KxNKj6ZKFfBNYpLo0uCh1JV-RCKGtDbePCiNjkhbMCx70F61KgKjOC9a1J8u37Ms2vH8shP7mv4z5YLw43S1cubx155Ks85KuH4RWEe9VR895FRUb0-qTxof_rJNx5APc7CMs-tXvuIay58hHcnnVG-scoqXE0ipYx5OLKvpDvJNuaV4v6kiFEZgg52Xbr4TevWVUwirxugtDwcWMuegKHN7KmT2FUVqV7DgwhURDkgQ0d6svCKFR_JArszHcx55nMxiD6JUvzLo05VdM4TXtzejJJ0n8Xegze8NaiTePxn_4bPTXSjqnrdLkFx_B2aEZ2JBtLVrrqHPtQRKqWkVbX9BE6lDExyRietQQefooLIaSK8QvhCumHDpQOfLWlnP9o0oILhbqvCHCqK5skbQNqycvAR_DPUS6SsbrLKODrF9dP9Q3cmR7M9tP93WTvJdzlTTUQ8ubZgNHZr3P3CjHZmXndMQKD45vmvT_NPESi
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkSokhHh3oYCR4Bht_I4PFQK2S0vpigOV9hbi2BGromQhrar-tf46ZvJalkrl1GviPPyY8Teeb2YIeZPDFoz7egTgW0bSg52S8OAjp5UTEiBp1sRxH830_rH8PFfzDXLZx8IgrbLXiY2i9lWOZ-RjJpgyAt0646KjRXydTN8tf0VYQQo9rX05jXaJHIaLczDf6t2DCcz1W86ne98-7kddhYEoVwmY0hn3gKiZZw5gjEyciBNvpQMzKDNxwXxQXDpdFDqRociFUN4b7W3hhHV5EbyA994it-G_GMqYmZtVwt_YyiFTeaxtH7ZnzbgM5er8kSexyg1f3xavYN2rlM275xW60-uThk3_1544vU_udWCWvm9X3wOyEcqHZOuoc9c_Ap0Nb8O4GYdkV_oJWZT0w6Ja1hcUwDIF8EknLddvUdOqoBiD3YSjweXGcfSYHN_IiD4hm2VVhm1CARwxljNvAljOwikwhCSo7iwOlvNMZiMi-iFL8y6hOdbV-Jn2jvXZ3iz9d6BHJBqeWrYJPf7TfqefjbQT7zpdLcYReT3cBsFEb0tWhuoM2mBsqpaJVte0EdpIi-IyIk_bCR5-igshpLLwBbM29UMDTAy-fqdc_GgShAsFVrBg0NW1RZK2obXIN4jBDOCgIdFt3eUWiPWz67v6imyBxKVfDmaHz8kd3pQFQVrPDtk8_X0WXgA4O3UvGymg5PtNi90fglpHcg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Submandibular+Gland+Biopsy+for+the+Diagnosis+of+Parkinson+Disease&rft.jtitle=Journal+of+neuropathology+and+experimental+neurology&rft.au=Beach%2C+Thomas+G&rft.au=Adler%2C+Charles+H&rft.au=Dugger%2C+Brittany+N&rft.au=Serrano%2C+Geidy&rft.date=2013-02-01&rft.issn=0022-3069&rft.volume=72&rft.issue=2&rft.spage=130&rft.epage=130&rft_id=info:doi/10.1097%2Fnen.0b013e3182805c72&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3069&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3069&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3069&client=summon